Umbilical cord blood stem cells: Clinical trials in non-hematological disorders

British Medical Bulletin

Volumn 102, Issue 1, 2012, Pages 43-57

  Ilic, Dusko ^a,c   Miere, Cristian ^a   Lazic, Emilija ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Mother and Child Health Care Institute   (Serbia)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

clinical trials; non hematological disorders; umbilical cord blood stem cells

Indexed keywords

BIOLOGICAL PRODUCT; CARTISTEM; NEUROSTEM AD; PNEUMOSTEM; UNCLASSIFIED DRUG;

ALBERS SCHOENBERG DISEASE; ALZHEIMER DISEASE; AUTISM; AUTOLOGOUS STEM CELL TRANSPLANTATION; BURN; CARTILAGE INJURY; CEREBRAL PALSY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); CORD BLOOD STEM CELL TRANSPLANTATION; CRITICAL LIMB ISCHEMIA; CRYOPRESERVATION; DIABETES MELLITUS; DRUG EFFICACY; EPIDERMOLYSIS BULLOSA; FOLLOW UP; HEALTH CARE FACILITY; HEARING LOSS; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INBORN ERROR OF METABOLISM; LUNG DYSPLASIA; MESENCHYMAL STEM CELL; NON HEMATOLOGIC DISEASE; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; STANDARDIZATION; STEM CELL RESEARCH; STROKE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; UMBILICAL CORD BLOOD;

BLOOD BANKS; CLINICAL TRIALS AS TOPIC; CORD BLOOD STEM CELL TRANSPLANTATION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMANS;

EID: 84861798100     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/lds008     Document Type: Review

References (52)

1. Gluckman E, Broxmeyer HA, Auerbach AD et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989;321:1174-8. (Pubitemid 19255814)
2. Gluckman E, Ruggeri A, Volt F et al. Milestones in umbilical cord blood transplantation. Br J Haematol 2011;154:441-7.
3. Broxmeyer HE. Insights into the biology of cord blood stem/progenitor cells. Cell Prolif 2011;44(Suppl. 1):55-9.
4. Zhao Y, Mazzone T. Human cord blood stem cells and the journey to a cure for type 1 diabetes. Autoimmun Rev 2010;10:103-7.
5. Arrojo IP, Lamas MD, Verdugo LP et al. Trends in cord blood banking. Blood Transfus 2012;10:95-100.
6. Querol S, Rubinstein P, Marsh SG et al. Cord blood banking: 'providing cord blood banking for a nation'. Br J Haematol 2009;147:227-35.
7. Fox NS, Chervenak FA, McCullough LB. Ethical considerations in umbilical cord blood banking. Obstet Gynecol 2008;111:178-82.
8. Fox NS, Stevens C, Ciubotariu R et al. Umbilical cord blood collection: do patients really understand? J Perinat Med 2007;35:314-21. (Pubitemid 47036977)
9. Bray RA, Hurley CK, Kamani NR et al. National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants. Biol Blood Marrow Transplant 2008;14:45-53.
10. Kurtzberg J, Laughlin M, Graham ML et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157-66. (Pubitemid 26249452)
11. Kamani N, Spellman S, Hurley CK et al. State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants. Biol Blood Marrow Transplant 2008;14:1-6. (Pubitemid 350286749)
12. Eapen M, Klein JP, Sanz GF et al. Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis. Lancet Oncol 2011;12:1214-21.
13. Kurtzberg J, Prasad VK, Carter SL et al. Results of the cord blood transplantation study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood 2008;112:4318-27.
14. Cornetta K, Laughlin M, Carter S et al. Umbilical cord blood transplantation in adults: results of the prospective cord blood transplantation (COBLT). Biol Blood Marrow Transplant 2005;11:149-60. (Pubitemid 40186212)
15. Kogler G, Enczmann J, Rocha V et al. High-resolution HLA typing by sequencing for HLA-A,-B,-C,-DR,-DQ in 122 unrelated cord blood/patient pair transplants hardly improves long-term clinical outcome. Bone Marrow Transplant 2005;36:1033-41. (Pubitemid 43078130)
16. Gibbons R. Analysis of the NYBC, NMDP and NHLBI cord blood data. In: Cord Blood: Establishing a National Hematopoietic Stem Cell Bank Program. Washington, D.C The National Academies Press, 2005,265-73.
17. Wagner JE, Barker JN, DeFor TE et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002;100:1611-8. (Pubitemid 34925136)
18. Ohnuma K, Isoyama K, Ikuta K et al. The influence of HLA genotyping compatibility on clinical outcome after cord blood transplantation from unrelated donors. J Hematother Stem Cell Res 2000;9:541-50.
19. Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placentalblood transplants from unrelated donors. N Engl J Med 1998;339:1565-77. (Pubitemid 28536131)
20. Yang H, Loutfy MR, Mayerhofer S et al. Factors affecting banking quality of umbilical cord blood for transplantation. Transfusion 2011;51:284-92.
21. Migliaccio AR, Adamson JW, Stevens CE et al. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000;96:2717-22.
22. Gluckman E, Rocha V, Boyer-Chammard A et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997;337:373-381.
23. Wagner JE, Rosenthal J, Sweetman R et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 1996;88:795-802. (Pubitemid 26333297)
24. Lee HJ, Lee JK, Lee H et al. The therapeutic potential of human umbilical cord bloodderived mesenchymal stem cells in Alzheimer's disease. Neurosci Lett 2010;481:30-5.
25. Yong VW, Rivest S. Taking advantage of the systemic immune system to cure brain diseases. Neuron 2009;64:55-60.
26. Enstrom AM, Van de Water JA, Ashwood P. Autoimmunity in autism. Curr Opin Investig Drugs 2009;10:463-73.
27. de Mara CS, Duarte AS, Sartori-Cintra AR et al. Chondrogenesis from umbilical cord blood cells stimulated with BMP-2 and BMP-6. Rheumatol Int 2012 [Epub ahead of print].
28. Berg L, Koch T, Heerkens T et al. Chondrogenic potential of mesenchymal stromal cells derived from equine bone marrow and umbilical cord blood. Vet Comp Orthop Traumatol 2009;22:363-70.
29. Kao IT, Yao CL, Chang YJ et al. Chondrogenic differentiation of human mesenchymal stem cells from umbilical cord blood in chemically synthesized thermoreversible polymer. Chin J Physiol 2008;51:252-8.
30. Kosmacheva SM, Volk MV, Yeustratenka TA et al. In vitro growth of human umbilical blood mesenchymal stem cells and their differentiation into chondrocytes and osteoblasts. Bull Exp Biol Med 2008;145:141-5.
31. Carroll JE, Mays RW. Update on stem cell therapy for cerebral palsy. Expert Opin Biol Ther 2011;11:463-71.
32. Burt RK, Testori A, Oyama Y et al. Autologous peripheral blood CD133 + cell implantation for limb salvage in patients with critical limb ischemia. Bone Marrow Transplant 2010;45:111-6.
33. Zhao Y, Lin B, Darflinger R et al. Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in non-obese diabetic (NOD) mice. PLoS ONE 2009;4:e4226.
34. Zhao Y, Jiang Z, Zhao T et al. Reversal of type 1 diabetes via islet beta cell regeneration following immune modulation by cord blood-derived multipotent stem cells. BMC Med 2012;10:3.
35. Haller MJ, Viener HL, Wasserfall C et al. Autologous umbilical cord blood infusion for type 1. diabetes. Exp Hematol 2008;36:710-5.
36. Haller MJ, Wasserfall CH, Hulme MA et al. Autologous umbilical cord blood transfusion in young children with type 1 diabetes fails to preserve C-peptide. Diabetes Care 2011;34:2567-9.
37. Petrova A, Ilic D, McGrath JA. Stem cell therapies for recessive dystrophic epidermolysis bullosa. Br J Dermatol 2010;163:1149-56.
38. Tolar J, Ishida-Yamamoto A, Riddle M et al. Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Blood 2009;113:1167-74.
39. Wagner JE, Ishida-Yamamoto A, McGrath JA et al. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med 2010;363:629-39.
40. Tolar J, Blazar BR, Wagner JE. Concise review: transplantation of human hematopoietic cells for extracellular matrix protein deficiency in epidermolysis bullosa. Stem Cells 2011;29:900-6.
41. Revoltella RP, Papini S, Rosellini A et al. Cochlear repair by transplantation of human cord blood CD133 + cells to nod-scid mice made deaf with kanamycin and noise. Cell Transplant 2008;17:665-78.
42. Wynn R. Stem cell transplantation in inherited metabolic disorders. Hematology Am Soc Hematol Educ Program 2011;2011:285-91.
43. Hobbs JR, Hugh-Jones K, Barrett AJ et al. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 1981;2:709-12. (Pubitemid 11061090)
44. Polgreen LE, Tolar J, Plog M et al. Growth and endocrine function in patients with Hurler syndrome after hematopoietic stem cell transplantation. Bone Marrow Transplant 2008;41:1005-11. (Pubitemid 352034175)
45. Miller WP, Rothman SM, Nascene D et al. Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report. Blood 2011;118:1971-8.
46. Steward CG, Blair A, Moppett J et al. High peripheral blood progenitor cell counts enable autologous backup before stem cell transplantation for malignant infantile osteopetrosis. Biol Blood Marrow Transplant 2005;11:115-21. (Pubitemid 40186208)
47. Orchard PJ, Dickerman JD, Mathews CH et al. Haploidentical bone marrow transplantation for osteopetrosis. Am J Pediatr Hematol Oncol 1987;9:335-40. (Pubitemid 18009277)
48. Boltze J, Reich DM, Hau S et al. Assessment of neuroprotective effects of human umbilical cord blood mononuclear cell subpopulations in vitro and in vivo. Cell Transplant 2011 [Epub ahead of print].
49. Boltze J, Kowalski I, Geiger K et al. Experimental treatment of stroke in spontaneously hypertensive rats by CD34 + and CD34-cord blood cells. Ger Med Sci 2005;3:Doc09.
50. Taguchi A, Soma T, Tanaka H et al. Administration of CD34 + cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 2004;114:330-8. (Pubitemid 39071605)
51. Farge D, Labopin M, Tyndall A et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica 2010;95:284-92.
52. Tyndall A. Successes and failures of stem cell transplantation in autoimmune diseases. Hematology Am Soc Hematol Educ Program 2011;2011:280-4.